No Contact Tracker generates $238/mo revenue with exceptional 99.8% profit margins and trades at an extremely attractive 1.75x annual profit multiple. The verified financials and clean business model are genuine strengths. However, the absolute revenue scale is modest, and critical traction metrics—user count, churn, organic vs. paid acquisition, and retention—are absent from the listing. A buyer must confirm these retention and growth dynamics before committing, as a health-focused mobile app's durability depends heavily on user engagement and repeat adoption.
Building a functional streak-tracking mobile app with push notifications and visual milestones is achievable in 6 weeks for $2.5K–$6K using AI-assisted development, Flutter or React Native, and managed cloud services. However, the primary asset being acquired is not the software—it is the verified $238/mo recurring revenue stream, the 11-month operating track record, and the proof that users will pay for this niche problem. Without confirmed retention, churn, and user-count data, the build case is stronger on software reproducibility alone. Given the modest revenue base and lack of traction detail, a builder could replicate the product quickly and test product-market fit independently, accepting the execution risk in exchange for full ownership and the ability to reinvest margins into growth channels. The presence of verified revenue and profitability tilts toward buy, but only if retention metrics are strong; otherwise, build and validate first.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
No Contact Tracker is a clean, effective mobile app designed to help users navigate breakups and maintain the "No Contact Rule." It features streak tracking, visual progress milestones, and daily moti
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.